Open Science for Health: Shaping the New Framework Programme

by JAUME VIDAL, Policy Advisor – Europe Health Action International (HAI) and Commons Network were joined last week in a packed room at the European Parliament by European Union lawmakers,…
Bobbi Klettke
7 February 2018

Staff Spotlight: Evelien Colenberg

The old saying that “money makes the world go round” is especially true for non-governmental organisations, like ours. Without it, HAI wouldn’t be able to realise our access to medicines…
Bobbi Klettke
16 January 2018

EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines

by JAUME VIDAL, Policy Advisor – Europe The European Union (EU) and Mercosur have been negotiating a free trade agreement for the last 16 years, with talks picking up pace…
Bobbi Klettke
14 December 2017

Facing a Global Threat – Roadmap to Combat Antimicrobial Resistance and the Bumps Along the Way

Interview with HELLE AARGAARD, Policy Advisor at ReAct – Action on Antibiotic Resistance The Member State Consultation on the World Health Organization’s (WHO) proposed roadmap for the Global Development and Stewardship Framework…
Bobbi Klettke
6 December 2017

The Forgotten Victims of Snakebite

by BIRTE BOGATZ, Communications Advisor Scola Kiplagat from Emsos, Kenya was just two when she died. Her cries awoke her parents on the night of her death, but they couldn’t…
Bobbi Klettke
30 November 2017

New Dutch Government Must Ensure Transparency to Control Medicine Prices

[vc_row][vc_column width=”2/3″][vc_column_text]by JAUME VIDAL After almost seven months of negotiations, The Netherlands has formed a new coalition government, which recently outlined its priorities and main policy objectives in its Coalition…
Bobbi Klettke
27 November 2017

HAI’s Research into Access to Sexual and Reproductive Health Commodities Now in Full Swing

by BOBBI KLETTKE, Communications Manager The methodology has been finalised. The pilot testing is complete. And data collection officials are trained. Health Action International’s study into the price, availability and affordability…
Bobbi Klettke
25 September 2017

Meet Callum Gunn: Our #InvaluableIntern & Rising TTIP Afficionado

Everyone’s heard about those internships where the main tasks are making coffee and copying and filing mountains of documents. Well, not at Health Action International (HAI)! Being an #InvaluableIntern here…
Bobbi Klettke
13 June 2017

Staff Spotlight: Mieke Bakx

In our new blog series, “Staff Spotlight”, we’re introducing you to people who are worth a mint to us: Our staff. What would an organisation like ours be without these…
Bobbi Klettke
16 May 2017

Staff Spotlight: Molly Lepeska

Only when all pieces of a puzzle are assembled do you see a picture. The pieces come in different shapes and sizes, but each has a purpose—and missing one will…
Bobbi Klettke
4 April 2017

European Commission Appoints Health Action International to HTA Network Stakeholder Pool

By Ancel.la Santos | Senior Policy Advisor Health Action International (HAI) was yesterday announced as a member of the Health Technology Assessment (HTA) Network Stakeholder Pool. The Pool has been…
Bobbi Klettke
15 February 2017

Health Action International Launches Study to Examine Access to Sexual and Reproductive Health Commodities in Kenya, Uganda and Zambia

by BOBBI KLETTKE New mothers sit with their babies in Kenya. Health Action International is researching barriers that are preventing people from accessing sexual and reproductive health commodities in Kenya,…
Bobbi Klettke
13 December 2016

Clinical Trial Data Transparency on Trial – EMA Under Pressure From Pharma Lawsuit

Thursday 1 December 2016 | Clinical Trial Data | Blog Posts |  Updated 22 December 2016 By Ancel.la Santos, Policy Advisor, Health Action International For too long, pharmaceutical companies have…
Bobbi Klettke
1 December 2016

November is ‘Intern Spotlight Month’ at Health Action International

November is ‘Intern Spotlight Month’ here at Health Action International (HAI), when we shine a light on the interns who make tremendous contributions to our team and the work we do…
Bobbi Klettke
1 November 2016

Conference on Clinical Drug Trials is Coming Up—and You’re Invited

Clinical trials are key to determining the safety and efficacy of medicines. But to do so, trials must be robust and ethical—and their full results must be reported publicly. Unfortunately, many…
Bobbi Klettke
5 September 2016

Next Gen Advocates Excel at HAI/HP4L Summer School on Access to Medicines

[vc_row][vc_column][vc_column_text]by Ancel.la Santos Quintano, Policy Advisor, Health Action International A strong civil society is an essential component of an advanced democracy. To facilitate participation in policy-making processes, civil society groups need…
Bobbi Klettke
27 July 2016

Farewell to Access to Medicines Pioneer, Andrew Herxheimer

by TIM REED With a heavy heart, I write with news of the passing HAI founder, life member of the HAI European network, and our dear friend, Andrew Herxheimer, who passed away…
Bobbi Klettke
23 February 2016

Insulin Still Unattainable for Many Living with Diabetes Worldwide: ACCISS Study Review in The Lancet D&E

by MOLLY LEPESKA An ACCISS Study Review of the global insulin market, called ‘Constraints and Challenges in Access to Insulin: A Global Perspective, was published Friday in The Lancet Diabetes…
Bobbi Klettke
6 February 2016

HAI Launches Innovative Global Study to Improve Access to Insulin

by MARG EWEN, Global Pricing Co-ordinator and ACCISS Study Co-investigator The global need for insulin, a hormone that converts sugar, starches and other food into needed energy for everyday activities,…
Chris Verra Media
16 January 2015